Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 2Venous Thromboembolism 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Venous Thormboembolism 1Thrombosis 1Small Cell Lung Carcinoma 1Pulmonary Embolism 1Colorectal Neoplasms 1Catheter-Related Infections 1Carcinoma, Pancreatic Ductal 1

Interventions

Enoxaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Venous Thormboembolism × Enoxaparin × Clear all
NCT02706249 2021-07-08

Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Dana-Farber Cancer Institute

Phase 2 Completed
50 enrolled 7 charts

Venous Thormboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡